What's New
Forgot Password
New Users
Corporate Info
IPO
News
Other Markets
MF Schemes
MF Trends
MF Buzz
MF Tools
Knowledge
MF Disclosure
Insurance
Reports
Tools
BSE
Quotes
MARKET ANALYSIS
NEWS
CORPORATE INFORMATION
CORPORATE ACTIONS
OTHER MARKETS
Gainers & Losers
Live Indices
Index Movers
Value & Volume Toppers
Advances & Declines
Only Buyers/Sellers
Bulk Deals
Block Deals
Sector Watch
New Highs & Lows
52 Week Highs & Lows
Out/Under Performers
Index Constituents
Unusual Volume
Historical Returns
Exchange Holidays
Pre-Session
Mid-Session
End-Session
Quick Peek
Market Beat
Stock Alert
Corporate Results
Foreign Markets
Economy News
Corporate News
Other Markets
Futures Market
Analyst Poll
Hot Pursuit
Business News
MutualFund News
IPO News
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Quarterly Result
Balance Sheet
Financial Ratios
Share Price
Director's Report
Score Board
MF Holdings
Share Holding Pattern
Name Change
Price Chart
Share Price Analysis
Company News
Peer Comparison
Interactive Chart
BSE Announcements
Board Meetings
Book Closure
Bonus Issues
Rights Issues
Delisted Shares
Market Turnover
Change of Name
Split Of Face Value
ADR Prices
FII Investment
MF Investment
Forex
World Indices
Your Result on :
Company News
Alembic Pharmaceuticals Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
533573
ISIN Demat
INE901L01018
Book Value (
R
s
)
304.2988178
NSE Symbol
APLLTD
Divident Yield %
1.24
Market Cap
(
R
s
In Cr.)
18,984
P/E (TTM)
18.63
EPS (TTM)
51.84
Face Value
(
R
s
)
2
Date
Heading
06-Nov-26
Tata Teleservices (Maharashtra) Ltd leads gainers in 'A' group
05-Nov-26
Alembic Pharmaceuticals consolidated net profit rises 81.46% in the Se
30-Oct-26
Alembic Pharmaceuticals receives USFDA approval for Venetoclax Tablets
29-Oct-26
Alembic Pharmaceuticals to declare Quarterly Results
04-Aug-26
Alembic Pharmaceuticals consolidated net profit rises 12.11% in the Ju
28-Jul-26
Alembic Pharmaceuticals receives USFDA approval for Prucalopride Table
25-Jul-26
Alembic Pharmaceuticals announces board meeting date
20-Jul-26
Alembic Pharma gains after partner NATCO receives USFDA tentative nod
11-Jul-26
Alembic Pharmaceuticals to conduct AGM
29-Jun-26
Alembic Pharma rises after receiving USFDA approval for Dapsone Gel, 5%
27-Jun-26
Alembic Pharmaceuticals receives USFDA final approval for Dapsone Gel
26-Jun-26
Alembic Pharmaceuticals receives USFDA approval for Oseltamivir Phosph
19-Jun-26
Alembic Pharmaceuticals receives USFDA approval for Binimetinib Tablet
19-Jun-26
Alembic Pharma gains after receiving USFDA tentative approval for Bini
12-Jun-26
Alembic Pharmaceuticals receives USFDA approval for Tretinoin Cream US
PREV |
NEXT
Risk Factor
|
Terms & Conditions
|
Privacy Policy
|
Disclaimer
|
Sitemap
Important Links:
SEBI
|
NSE
|
BSE
|
MCX
|
NCDEX
|
NSDL
|
CDSL
|
FMC
BSE Delayed market data sourced at 5 minutes –
www.bseindia.com
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved.
Designed, Developed , Maintained and Content Powered by
CMOTS InfoTech
(ISO 9001:2015 & ISO/IEC 27001:2022 Certified)